#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14920	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2112	701.7	0	.	n	.	0	A69G	SNP	69	69	A	308	308	G	833	G	762	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14920	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2112	701.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1689	1689	T	822	T	759	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14920	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2112	701.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1423	1423	C	899	C	830	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27362	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3605	756.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1636	1636	A	879	A,G	800,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27362	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3605	756.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2270	2270	C	898	C,T	826,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27362	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3605	756.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2344	2344	A	888	A,T	826,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27362	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3605	756.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2896	2896	C	827	C	761	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	8	blaTEM	861	230	99.57	blaTEM.l15.c4.ctg.1	230	1.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	1992	folP	852	852	99.88	folP.l15.c30.ctg.1	1279	153.4	0	.	p	.	0	E151K	NONSYN	451	453	GAA	658	660	AAA	185;186;186	A;A;A	174;175;175	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	1992	folP	852	852	99.88	folP.l15.c30.ctg.1	1279	153.4	1	SNP	p	R228S	1	.	.	682	684	AGC	889	891	AGC	198;196;197	A;G;C	182;179;178	folP.WHO_N_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5190	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3266	158.4	1	SNP	p	S91F	0	.	.	271	273	TCC	557	559	TCC	193;194;194	T;C;C	173;177;178	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5190	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3266	158.4	1	SNP	p	D95G	0	.	.	283	285	GAC	569	571	GAC	193;194;192	G;A;C	175;178;178	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5190	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3266	158.4	1	SNP	p	D95N	0	.	.	283	285	GAC	569	571	GAC	193;194;192	G;A;C	175;178;178	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1574	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1219	127.3	1	SNP	p	G45D	0	.	.	133	135	GGC	483	485	GGC	190;187;186	G;G,C;C	173;169,1;169	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	760	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1005	75.4	0	.	n	.	0	A197.	DEL	197	197	A	533	533	A	188	A	177	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5680	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2850	198.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1588	1590	GCA	235;238;236	G;C;A,G	214;216;209,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5680	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2850	198.1	1	SNP	p	D86N	0	.	.	256	258	GAC	541	543	GAC	224;223;218	G;A;C	208;202;201	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5680	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2850	198.1	1	SNP	p	S87I	0	.	.	259	261	AGT	544	546	AGT	219;220;223	A;G;T	202;203;198	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5680	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2850	198.1	1	SNP	p	S87W	0	.	.	259	261	AGT	544	546	AGT	219;220;223	A;G;T	202;203;198	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5680	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2850	198.1	1	SNP	p	S87R	0	.	.	259	261	AGT	544	546	AGT	219;220;223	A;G;T	202;203;198	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5680	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2850	198.1	1	SNP	p	S88P	0	.	.	262	264	TCC	547	549	TCC	218;218;220	T;C;C	197;199;203	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4170	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2635	157.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1555	1557	GGC	203;202;203	G;G,A;C	188;186,1;183	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3916	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2337	166.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1264	1266	GCA	207;210;213	G;C;A	191;194;197	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3916	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2337	166.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1267	1269	ATC	213;215;213	A;T;C	195;195;194	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3916	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2337	166.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1279	1281	GTG	210;207;209	G;T;G	194;190;191	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3916	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2337	166.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1279	1281	GTG	210;207;209	G;T;G	194;190;191	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3916	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2337	166.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1783	1785	ACC	199;197;195	A;C;C	177;182;181	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3916	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2337	166.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1837	1839	GCG	189;189;192	G;C;G	169;150;166	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3916	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2337	166.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1837	1839	GCG	189;189;192	G;C;G	169;150;166	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3916	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2337	166.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1960	1962	GGC	179;178;179	G,A;G;C	161,1;158;159	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3916	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2337	166.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1969	1971	GGC	173;173;175	G;G;C	155;155;156	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3916	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2337	166.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1987	1989	CTG	164;164;161	C;T,C;G	133;123,1;130	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5702	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3043	186.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1612	1614	CCG	202;204;203	C;C;G	183;190;188	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2174	porA	1146	1146	99.65	porA.l6.c4.ctg.1	1752	123.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	520	520	C	155	C	139	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2754	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1658	165.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	398	400	GAA	261;261;260	G;A;A	241;242;245	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2754	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1658	165.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	686	688	GAT	237;237;238	G;A;T	224;224;223	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2754	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1658	165.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	809	811	TCA	232;231;232	T;C;A	217;216;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2754	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1658	165.1	0	.	p	.	0	A218I	NONSYN	652	654	GCC	938	940	ATC	211;211;213	A;T;C	200;200;200	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2754	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1658	165.1	0	.	p	.	0	W257L	NONSYN	769	771	TGG	1055	1057	TTG	209;208;211	T;T;G	199;200;200	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2754	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1658	165.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1268	1270	GCA	236;235;234	G;C;A,G	216;212;213,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2754	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1658	165.1	1	SNP	p	G120K	1	.	.	358	360	AAG	644	646	AAG	215;213;214	A;A;G	200;198;199	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2754	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1658	165.1	1	SNP	p	A121D	1	.	.	361	363	GAC	647	649	GAC	215;213;214	G,T;A;C	198,1;195;197	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2754	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1658	165.1	1	SNP	p	D121N	0	.	.	361	363	GAC	647	649	GAC	215;213;214	G,T;A;C	198,1;195;197	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	340	porB3	990	116	92.24	porB3.l15.c17.ctg.1	476	28.9	0	.	p	.	0	M18T	NONSYN	52	54	ATG	370	372	ACG	70;69;67	A;C;G	60;59;56	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	340	porB3	990	116	92.24	porB3.l15.c17.ctg.1	476	28.9	0	.	p	.	0	T29A	NONSYN	85	87	ACC	403	405	GCC	58;54;52	G,A;C;C	47,1;43;42	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	340	porB3	990	116	92.24	porB3.l15.c17.ctg.1	476	28.9	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	412	414	CAA	39;35;33	C;A;A	34;32;30	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	340	porB3	990	116	92.24	porB3.l15.c17.ctg.1	476	28.9	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	418	420	TAC	25;22;22	T;A;C	24;22;22	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10750	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4859	220.4	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2011	2013	CAT	258;258;261	C;A;T	235;233;234	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1162	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1023	113.0	1	SNP	p	V57M	1	.	.	169	171	ATG	478	480	ATG	239;242;242	A,G;T;G	222,1;226;224	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
